Apparently he's a self-trained biologist too.
http://www.bloomberg.com/bw/article...eli-the-biotech-short-seller-who-went-long#p1
http://www.bloomberg.com/bw/article...eli-the-biotech-short-seller-who-went-long#p1
Apparently he's a self-trained biologist too.
http://www.bloomberg.com/bw/article...eli-the-biotech-short-seller-who-went-long#p1
Apparently he's a self-trained biologist too.
http://www.bloomberg.com/bw/article...eli-the-biotech-short-seller-who-went-long#p1
Yeah, just want to point out that this information is a bit dated, and he was fired and sued by the same people who were praising him in that article.
I am sorry, I heard "Self-trained blowhard" the first time.Yeah, just want to point out that this information is a bit dated, and he was fired and sued by the same people who were praising him in that article.
Has he stopped claiming to be a self-trained biologist? If not then that information is still good.
Has anybody calculated what should have been the price for this drug (since the company was price dumping)
Are you suggesting patent protection should last forever? Or are you suggesting there's a metaphysical difference between cheap generics from India and cheap generics from a non-drug-developing company in a drug-developing powerhouse like Europe?It's not about cheap indian generics. India does not develop drugs, US does. So if you let Indian drugs in, developments will eventually stop.
What gave you this impression?Are you suggesting patent protection should last forever?It's not about cheap indian generics. India does not develop drugs, US does. So if you let Indian drugs in, developments will eventually stop.
Or are you suggesting there's a metaphysical difference between cheap generics from India and cheap generics from a non-drug-developing company in a drug-developing powerhouse like Europe?
dismal, here it is:Meh, greedy and evil CEO is so dog-bites-man.
The man-bites-dog story here is the insufficiently greedy and evil CEO who was only charging $13.50.
Source:Salk campaigned for mandatory vaccination, claiming that public health should be considered a "moral commitment." His sole focus had been to develop a safe and effective vaccine as rapidly as possible, with no interest in personal profit. When asked who owned the patent to it, Salk said, "There is no patent. Could you patent the sun?"
To be fair Infectious diseases is a separate and special case.dismal, here it is:
Source:Salk campaigned for mandatory vaccination, claiming that public health should be considered a "moral commitment." His sole focus had been to develop a safe and effective vaccine as rapidly as possible, with no interest in personal profit. When asked who owned the patent to it, Salk said, "There is no patent. Could you patent the sun?"Jonas Salk
He was a biomedical researcher, not a business leader, however. Enjoy hating him for being a disgusting socialist, dismal.
What I wrote was a perfectly appropriate response to the idiocy I was answering. If that idiocy was off-topic in this thread then it was that post's author who derailed the thread, not me, so take your complaints to ksen. Oh, wait. ksen is the Original Poster. If he wants to use his thread to talk about "free marketjism", who are we to overrule him?Actually I remarked as I did because I took your response, which had to have had something to do with the OP as being in support of what the guy did because the posts reading otherwise have been quite clear with their opposition.
I suppose I also assumed you weren't derailing the thread.
Hey, I wasn't arguing pharmaceuticals are well-suited to free markets, just that it's irrational to blame free markets for a guy hacking a vulnerability built into the regulatory system of the most non-free market in the country. A free market would of course have its own set of vulnerabilities.Which is why we have anti-monopoly laws and the FDA. Free market babes!!!A free market is very resilient against this sort of abuse.
What gave you this impression?Are you suggesting patent protection should last forever?
Um, the fact that you're proposing excluding them from competing with us at production of a drug whose patent expired forty years ago?I am suggesting that India strictly speaking steals intellectual property, that is, they don't develop drugs yet they produce them for internal use.
"Free markets suck"
I don't think I am proposing that. I mentioned India in more general aspect of drug business.What gave you this impression?Um, the fact that you're proposing excluding them from competing with us at production of a drug whose patent expired forty years ago?
I am suggesting that India strictly speaking steals intellectual property, that is, they don't develop drugs yet they produce them for internal use.
The real problem is exactly as you have identified - this stuff is so cheap to make, and so expensive to get set up and licensed to make, that the only way for it to be profitable is for it to be a monopoly. Which opens the door to assholes who decide that margins in the 100 - 200% range are not enough, and want to abuse their monopoly position, knowing that the patients cannot simply stop taking the drugs.
In such a situation, there are three choices - 1) Accept the extortion and pay the asshole whatever he demands; 2) Lower the regulatory hurdles until competition becomes viable, and let the market push the price down; or 3) Regulate the price as well as the manufacturing and supply process.
Option 1 is unacceptable for reasons which I hope are obvious. Option 2 opens up the prospect of poor quality and/or fake drugs finding their way to patients; so Option 3 is really the only workable solution - despite the horror that government price controls evoke in the free market evangelists.
This is one area where the free market simply cannot work - customers are not able to determine the quality of the product, because the difference between a tablet that will save your life and a tablet that will do nothing at all (or may even poison you) is only able to be determined by highly skilled people working in a well equipped laboratory. Free markets rely on the customers having at least some way to tell what the quality of the goods is; and with pharmaceuticals, this is really not possible. So some central trusted authority is needed to protect the customers from unscrupulous suppliers.
In an unregulated marketplace, only fake tablets can be sold - because the counterfeiters can always undercut the legitimate suppliers; and the customers have no way to spot the difference between a real product and a fake.
On April 3, 2014, Retrophin, Inc. (the “Registrant”) provided notice to the wholesaler of its Chenodal® product that effective immediately, the Registrant had increased the price of a package of 100 250mg tablets of Chenodal from $9,460 to $47,300.